uced gastritis, we anticipated a negative correlation between SLPI and Pro granulin for this disease. The H. pylori induced reduction of mucosal SLPI levels resulted in higher elastase activities that were expected to degrade Progranulin leading subse quently to diminished mucosal Progranulin sellckchem levels. In con trast to our working hypothesis, we identified an increase of mucosal Progranulin levels in the antrum of H. pylori infected subjects. Furthermore, correlation analyses revealed rather a trend or even a posi tive correlation between both proteins implying that the proposed regulatory link between SLPI and Progranulin is not present in this disease. The fact that increased Progranulin levels were mostly restricted to antral mucosa suggests an association of this upregulation with the degree of gastritis.

As pre viously demonstrated, all probands presented antrum predominant gastritis that was associated with moderate and severe activity scores reflecting the number of infil trating granulocytes and lymphocytes. As shown in immunohistochemical stainings of the study, immune cells were strongly positive for Progranulin and represent a major source of mucosal Progranulin levels in addition to gastric epithelial cells. Collectively, data of immunohis tochemistry correspond to quantitative assessment of Progranulin by ELISA supporting the identified upregula tion of Progranulin in H. pylori infection. Interestingly, H. pylori negative subjects revealed sig nificant higher progranulin transcript levels, which were associated with lower protein levels, compared to those of the H.

pylori positive and eradicated group. The missing concordance between transcriptional and pro tein level is not easily explained and remains unclear. One potential explanation might be different regulatory mechanisms of Progranulin expression in gastric epithe lial cells of H. pylori negative subjects, who have been negative for the complete life compared to individuals after successful eradication therapy being without H. pylori infection for several months only. As shown recently for mucosal infiltration and by the numbers of Progranulin expressing immune cells in this study, sam ples from patients after eradication therapy contained still lymphocytes leading to slightly higher chronicity scores or slightly increased Progranulin scores com pared to H. pylori negative subjects.

Since in H. pylori positive subjects, two major Progranulin expressing cell types are simultaneously Anacetrapib present, Progranulin transcript levels can not be assessed individually for each cell type. Despite the miss ing concordance between protein and transcript levels, it should be emphasized that the mucosal levels of Progra nulin were found to be significantly upregulated in H. pylori infected subjects. The results obtained in the AGS cell model do par tially not correspond to the ex vivo findings. While Abiraterone buy ex vivo data demonstrated an upregulation of Progranulin by H. pylori, in the AGS cell model, only th